[1] 国家心血管病中心. 中国心血管健康与疾病报告2019[M]. 北京: 科学出版社, 2020.
[2] DALEN J, ALPERT J, GOLDBERG R, et al. The Epidemic of the 20th Century: Coronary Heart Disease[J]. Am J Med, 2014, 127(9): 807. doi: 10.1016/j.amjmed.2014.04.015
[3] GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1736. doi: 10.1016/S0140-6736(18)32203-7
[4] LI D, ZHAO L, YU J, et al. Lipoprotein-associated phospholipase A2 in coronary heart disease: Review and meta-analysis[J]. Clin Chim Acta, 2017, 465: 22. doi: 10.1016/j.cca.2016.12.006
[5] HANDSCHUMACHER RE, HARDING MW, RICE J, et al. Cyclophilin: a specific cryptozoic binding protein for cyclosporine A[J]. Science, 1984, 226(4674): 544. doi: 10.1126/science.6238408
[6] BONFILS C, BEE N, LARROQU C, et al. Cyclophilin A as negative regulator of apoptosis by aequestering cytochrome[J]. Biochen Biophy Res Commun, 2010, 393(2): 325. doi: 10.1016/j.bbrc.2010.01.135
[7] NURKIC J, LJUCA F, NURKIC M, et al. Biomarkers of plaque instability in acute coronary syndrome patients[J]. Med Arh, 2010, 64: 103.
[8] Grad E, DANENBERG HD. C-reactive protein and atherothrombosis: Cause or effect?[J]. Blood Rev, 2013, 27(1): 23. doi: 10.1016/j.blre.2012.12.001
[9] GENSINI GG. A more meaningful scoring system for determining the severity of coronary heart disease[J]. 1983, 51(3): 606.
[10] DE WILDE AH, PHAM U, POSTHUMA CC, et al. Cyclophilins and cyclophilin inhibitors in nidovirus replication[J]. Virology, 2018, 522: 46. doi: 10.1016/j.virol.2018.06.011
[11] DAWAR FU, XIONG Y, KHATTAK MNK, et al. Potential role of cyclophilin A in inregulating cytokine secretion[J]. J Leukoc Biol, 2017, 102(4): 988.
[12] SATOH K, FUKUMOTO Y, SUGIMURA K, et al. Plasma cyclophilin A is a novel biomarker for coronary artery disease[J]. Circ J, 2013, 77(2): 447. doi: 10.1253/circj.CJ-12-0805
[13] 刘霄岩, 赵晓静, 代江娜, 等. 老年冠心病患者血清亲环A、视黄醇结合蛋白4、胰岛素样生长因子-1水平与冠状动脉病变相关性[J]. 创伤与急危重病医学, 2020, 8(4): 259.
[14] 王诗奇, 周丽, 邹武松. 血清单核细胞趋化蛋白1、亲环素A与糖尿病合并高血压患者冠状动脉Gensini积分的相关性[J]. 中华高血压杂志, 2019, 27(6): 571.
[15] GIMBRONE MA, GARCÍA-CARDEA G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis[J]. Circ Res, 2016, 118(4): 620. doi: 10.1161/CIRCRESAHA.115.306301
[16] RATH T, RODERFELD M, GRAF J, et al. Matrix metalloproteinases in inflammatory bowel disease-from basic research to clinical significance[J]. Z Gastroenterol, 2009, 47(8): 758. doi: 10.1055/s-0028-1109520
[17] 韦美玉, 张广利, 杨建国, 等. 血清25-羟基维生素D3水平、基质金属蛋白酶-9与冠心病的相关性研究[J]. 中西医结合心脑血管病杂志, 2020, 18(15): 2480. doi: 10.12102/j.issn.1672-1349.2020.15.026
[18] 张茵, 宋雷, 高展, 等. 血浆C反应蛋白水平与冠心病患者冠状动脉造影结果严重程度相关[J]. 中国分子心脏病学杂志, 2015, 2(9): 1273.
[19] HARADA K, AMANO T, UETANI T, et al. Association of inflammatory markers with the morphology and extent of coronary plaque as evaluated by 64-slice multidetector computed tomography in patients with stable coronary artery disease[J]. Int J Cardiovasc Imaging, 2013, 2(9): 233. doi: 10.1007/s10554-013-0181-2
[20] 王玉东, 马广蕊, 杨冬梅, 等. 糖、脂类、C反应蛋白与冠心病患者Gensini积分的相关性研究[J]. 标记免疫分析与临床, 2016, 23(12): 1403.
[21] GEISLER T, BHATT DL. The role of inflammation in atherothrombosis: current and future strategies of medical treatment[J]. Med Sci Monit, 2004, 10(12): 308.
[22] 汝鹏, 李玉喜. 急性冠状动脉综合征病人血清中超敏肌钙蛋白、超敏C反应蛋白和同型半胱氨酸水平变化及临床意义[J]. 蚌埠医学院学报, 2019, 44(6): 758.
[23] 王蕊, 张鹏祥, 李飞星, 等. 急性冠脉综合征患者血清sCD40L和MMP-9水平变化与危险分层的相关性研究[J]. 基因组学与应用生物学, 2019, 38(8): 3868.